We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Cyclo Therapeutics, Inc. Warrant in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $1.66K → $0 (-$1.66K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.64K
2
UBS Group
UBS Group
Switzerland
-$13
3
Bank of America
Bank of America
North Carolina
-$12
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
– -$1.64K -11,693 Closed
UBS Group
2
UBS Group
Switzerland
– -$13 -175 Closed
Bank of America
3
Bank of America
North Carolina
– -$12 -160 Closed

CYTHW Hedge Fund Activity: Q1 2025 in Review

0 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q1 2025, worth a combined $0 — down 100% from $1.66K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CYTHW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, exiting entirely with an estimated $1.64K sold.

  • 0 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q1 2025, down from 3 in Q4 2024.
  • Funds reported $0 of Cyclo Therapeutics, Inc. Warrant stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q1 2025 and 3 closed out, a net change of -3 holders.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q1 2025 was Citadel Advisors, an estimated $1.64K sold.

Based on aggregated 13F filings for Q1 2025.